The DOI matches its Crossref record; 57 of the 62 references it cites were found in a registry or an index.
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment
Open accessAbstract
Objective To determine the prevalence of insulin resistance (IR) in a large population of patients with the polycystic ovary syndrome (PCOS).Design Prospective, case-control.Setting University medical center.Patient(s) Two hundred seventy-one PCOS patients and 260 eumenorrheic, non-hirsute, control women.Intervention(s) History and physical examination and blood sampling.Main outcome measure(s) Total T, free T, DHEAS, sex hormone-binding globulin, and fasting glucose and insulin levels; homeostatic model assessment values for IR (HOMA-IR) and percent beta-cell function (HOMA-%beta-cell).Result(s) Patients with PCOS and controls differed significantly in all parameters studied, except fasting glucose. Because the HOMA-IR and HOMA-%beta-cell values were variably associated with race, age, and body mass index, the HOMA-IR and HOMA-%beta-cell values were then adjusted for these cofounders. After adjustment, 64.4% of PCOS patients were noted to be insulin resistant, and 2.6% had beta-cell dysfunction. Compared with PCOS patients without IR (n = 96), patients with IR (n = 174) were more obese and had higher beta-cell function.Conclusion(s) In patients with PCOS, the prevalence of IR was 64% according to the HOMA-IR measurement, after adjustment. Patients with IR were more clinically affected. Although IR is a common abnormality in PCOS, it does not seem to be a universal feature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IR is present in around 50%80% of women with PCOS, independent of obesity, 101”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [101]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Self-citationBonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Lévy, J., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,023
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Self-citationLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Asunción, M., Calvo, R. M., Millán, J. L. S., Sancho, J., Ávila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,328
Flagged first, then by citations
5 of the 62 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 586
Wang, J., Gui, R., Li, Y., Li, Z., Li, Z., Liu, S., Zhang, M., Lu, Q., Fan, X., & Xiong, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119822 · Cited by 6
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Dogan, M. I., Taşçı, İ., Bulucu, F., Aydoğdu, A., Acar, R., Ceyhan, T., Koç, B., Demir, O., Gezer, M., & Sağlam, K. (2012) · Angiology · doi:10.1177/0003319711436248 · Cited by 5
Bhattacharjee, K., Kumar, B. A., Sinha, A., Swar, S., Maiti, A., & Praveen, D. (2018) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2018.05.00164 · Cited by 5
Vince, R. V., Kirk, R. J., Aye, M. M., Atkin, S. L., & Madden, L. A. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01048-1 · Cited by 5
Feferkorn, I., Badeghiesh, A. M., Mills, G., Baghlaf, H. A., & Dahan, M. H. (2021) · Human Reproduction · doi:10.1093/humrep/deab145 · Cited by 5
Wander, P. L., Enquobahrie, D. A., Bammler, T. K., MacDonald, J. W., Srinouanprachanh, S. L., Kaleru, T., Khakpour, D., & Trikudanathan, S. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111723 · Cited by 5
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_1 · Cited by 5
Self-citationÇağlar, G. S., Kiseli, M., Şeker, R., Ozdemir, E. D., Karadağ, D., & Demırtaş, S. (2015) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2015.99815 · Cited by 5
Balahoroğlu, R., Zirek, A. K., Çokluk, E., Atmaca, M., Şekeroğlu, M. R., & Huyut, Z. (2020) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.571510 · Cited by 5
Polycystic ovary syndrome: prognosis and risk of comorbidity
Hardy, T., Sousa, S. D., & Norman, R. J. (2013) · doi:10.2217/ebo.12.214 · Cited by 5
Tehrani, F. R., Fayaz, M., Firouzi, F., Azizi, F., Tohidi, M., & Behboudi‐Gandevani, S. (2025) · Endocrine Connections · doi:10.1530/ec-25-0266 · Cited by 4
Ege, S., Bademkıran, M. H., Peker, N., Özgün, Z., Bağlı, İ., Erdem, S., Erel, Ö., Özgökçe, Ç., & Gül, E. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1786033 · Cited by 4
Altemimi, M. T., musa, A. K., & Mansour, A. A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1431 · Cited by 4
Diet and exercise in the management of PCOS: Starting from the basics
Markantes, G. Κ., Tsichlia, G., & Georgopoulos, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00010-9 · Cited by 5
GÜRBÜZ, T., Gökmen, O., MADENLİ, A. A., & Dilbaz, B. (2023) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1210721 · Cited by 4
Defining prediabetes in polycystic ovarian syndrome
Trolice, M. P. (2011) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2011.12008 · Cited by 5
Park, K. S. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100454 · Cited by 5
Metabolic Syndrome in Polycystic Ovary Syndrome
Hsieh, Y.-C., Yang, P.-K., & Chen, M. (2021) · Fertility & Reproduction · doi:10.1142/s2661318221500158 · Cited by 4
Jensterle, M., Kravos, N. A., Dolžan, V., Goričar, K., Herman, R., Rizzo, M., & Janež, A. (2021) · Endocrine · doi:10.1007/s12020-021-02934-4 · Cited by 4
Sert, Z. S., Yılmaz, S. A., Kerimoğlu, Ö. S., Abuşoğlu, S., Ünlü, A., & Çelık, Ç. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02899-3 · Cited by 4
Handelsman, R. G., Wertheimer, S., VanHise, K., Buttle, R. A., Clark, E. L., Wang, E. T., Azziz, R., Pisarska, M. D., & Chan, J. L. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.09.004 · Cited by 4
Self-citationWang, Y., Xie, X.-M., Dai, M., & Zhu, W.-J. (2010) · Scientific Research and Essays · doi:10.5897/sre.9000798 · Cited by 4
Harnois‐Leblanc, S., Hernández, M. I., Ethel Codner, D., CASSORLA, F. G., Oberfield, S. E., Leibel, N. I., Mathew, R. P., Ten, S., Magoffin, D. A., Lane, C. J., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab812 · Cited by 4
Self-citationPolycystic Ovarian Syndrome in Taiwanese Women
Liang, S.-J., Chou, S.-Y., Wang, G.-C., Tzeng, C., Hsu, C.-S., & Hsu, M.-I. (2010) · Journal of Experimental & Clinical Medicine · doi:10.1016/s1878-3317(10)60034-4 · Cited by 4
Insulin resistance in polycystic ovary syndrome: maker or marker?
Bozdağ, G., & Yıldız, B. O. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.09.73 · Cited by 4
Heathcote, G., Boothroyd, C. V., Forbes, K. L., Lee, A., Gregor, M. F., & Luscombe, G. M. (2020) · Fertility & Reproduction · doi:10.1142/s2661318220500061 · Cited by 4
Yüce, E., Pabuçcu, R., Keskin, M., Arslanca, T., & Pabuçcu, E. (2020) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2020-80616 · Cited by 4
Functional and Structural Uterine Changes in PCOS
Zaborowska, Ł., Blok, J., Piotrkowicz, E., Lindheim, S. R., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167921 · Cited by 4
Does Polycystic Ovarian Syndrome Increase Insulin Resistance Above and Beyond Obesity?
Tan, M. J. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000142 · Cited by 3
ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations
Asadi, M., Klashami, Z. N., Panahi, N., Oheb, Y., Khorasani, S., & Amoli, M. M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01335-w · Cited by 3
Huang, S., Yu, C., Hu, M., Wen, Q., Wen, X., Li, S., Li, K., & Ma, H. (2023) · Acupuncture in Medicine · doi:10.1177/09645284231207863 · Cited by 3
Khalil, M. M., Ali, H. A., & Al-Hilo, M. A. H. (2022) · AIP conference proceedings · doi:10.1063/5.0066876 · Cited by 4
Aziz, M. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.473 · Cited by 2
Markantes, G. Κ., Saltamavros, A. D., Vervita, V., Armeni, A. K., Karela, A., Adonakis, G. L., Decavalas, G., & Georgopoulos, N. A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.569783 · Cited by 3
Bernardita Blümel, M., Mariana Flores, F., José Antonio González, G., & José Antonio Arraztoa, V. (2005) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262005000500012 · Cited by 3
Javed, A., Lteif, A. N., Kumar, S., Simmons, P. S., & Chang, A. Y. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.01.001 · Cited by 5
Hara, S., Takahashi, T., Igarashi, H., Amita, M., Matsuo, K., Hasegawa, A., & Kurachi, H. (2014) · Journal of Mammalian Ova Research · doi:10.1274/jmor.31.2 · Cited by 3
Etiología del síndrome del ovario poliquístico
Escobar-Morreale, H. F. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71165-2 · Cited by 3
Insulin sensitizers for women with polycystic ovarian syndrome
Galal, A. F., & Mitwally, M. F. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.183 · Cited by 4
The link between polycystic ovary syndrome and Type 2 diabetes: what do we know today?
Sathyapalan, T., & Atkin, S. L. (2011) · Diabetes Management · doi:10.2217/dmt.11.59 · Cited by 3
PCOS and metformin: from pharmacology to clinical use for women's health
Genazzani, A. D., Ricchieri, F., Prati, A., Chierchia, E., Rattighieri, E., Bosco, G., Despini, G., Campedelli, A., Farinetti, A., & Santagni, S. (2012) · IRIS UNIMORE (University of Modena and Reggio Emilia) · Cited by 3
Metabolische und reproduktionsmedizinische Aspekte des Polyzystischen Ovarsyndroms (PCOS)
Feichtinger, M., Linder, T., & Göbl, C. S. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0439-0 · Cited by 3
Dalal, M., Babu, M., & Rastogi, D. M. S. (2014) · IOSR Journal of Nursing and health Science · doi:10.9790/1959-03643942 · Cited by 3
Stassek, J., Ohnolz, F., Hanusch, Y., Schmidmayr, M., Berg, D., Kiechle, M. B., & Seifert‐Klauss, V. (2015) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0035-1558186 · Cited by 3
Tang, C., Li, X., Tang, S., Wang, Y., & Tan, X. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0506 · Cited by 3
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_8 · Cited by 3
Self-citationdo Vale, V. A. L., Sossi, L. M. C., Agnolin, A. A., Pinheiro, A. L. D. E. S., Souza, B. P. C., Ferrari, C. A., de Souza, G. S., Paticcié, G. F., Lourenço, M. H. T., & Martins, O. C. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n2-036 · Cited by 3
Haapakangas, S. M., Koskenkari, N. V. S., Hurskainen, E., Arffman, R. K., Ollila, M., & Piltonen, T. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01753-1 · Cited by 2
Veličković, N. A., Vratarić, M., Mićić, B., Teofilović, A., Radovanović, M., Ignjatović, S., Gašić, U., Djordjevic, A. D., Μacut, D., & Milutinović, D. V. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01103-9 · Cited by 2
Almubaddil, K. H., Alotaibi, M., Mutreb, L. B., Alanazi, F., & Altulihee, M. A. (2026) · Cureus · doi:10.7759/cureus.103927 · Cited by 4
Nastouli, K.-M., Apostolos, A., Bozika, M., Boliaris, G., Iliakis, P., Ktenopoulos, N., Vlachakis, P. K., Karakasis, P., Theodoropoulou, T., Tsiamis, N., et al. (2026) · Medicina · doi:10.3390/medicina62071313 · Cited by 3
Silva, A. F., & Motta, A. B. (2024) · Reproduction · doi:10.1530/rep-23-0325 · Cited by 3
Trouva, A., Alvarsson, M., Calissendorff, J., Åsvold, B. O., Ujvári, D., Hirschberg, A. L., & Vanky, E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1388473 · Cited by 2
Síndrome de ovario poliquístico y riesgo cardiovascular
Sesmilo, G., & González‐Sastre, F. (2007) · Medicina Clínica · doi:10.1157/13109704 · Cited by 2
Vieira, C. S., Gomes, M. K. O., Rodrigues, P. C., Pinto, A. P. M., dos Reis, R. M., Ferriani, R. A., & de Sá, M. F. S. (2007) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032007000300005 · Cited by 2
Infertility in women with polycystic ovary syndrome and the role of metformin in management
Boyle, J. A., Teede, H. J., & Misso, M. L. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.842689 · Cited by 2
Chronic Treatment of Polycystic Ovary Syndrome
Nader, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_9 · Cited by 2
Köksal, B., Yıldız, S., Ozgöcer, T., Yıldız, A., Vardı, N., & Barutçu, Ö. (2019) · AFMN Biomedicine · doi:10.5937/afmnai2001034k · Cited by 2
Okyay, R. E., Çetintaş, B., Akdöner, A., Öztura, İ., Yildirim, G. E., Çağlıyan, E., Yavuz, O., & Şişman, A. R. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2082403 · Cited by 2
Genetic variations in OLR1 gene associated with PCOS and atherosclerotic risk factors
Şahin, S. B., Nalkıran, İ., Ayaz, T., Güzel, A. İ., Eldeş, T., Calapoğlu, T., & Nalkıran, H. S. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221141831 · Cited by 2
Christou, M., Mintziori, G., Goulis, D. G., & Tarlatzis, B. C. (2023) · ISGE series · doi:10.1007/978-3-031-22378-5_8 · Cited by 2
Metabolic syndrome in patients with the polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., & Papadakis, E. P. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.853451 · Cited by 2
Motta, E. L. A., Domingues, T. S., & Soares, J. M. (2012) · PubMed · doi:10.1590/s0100-72032012000300001 · Cited by 2
Insulin Resistance and Hyperinsulinism in the Polycystic Ovary Syndrome
Essah, P. A., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_24 · Cited by 1
Al-fatlawiy, H. D. A., Ali, H. A., & Naser, A. F. (2022) · AIP conference proceedings · doi:10.1063/5.0067499 · Cited by 1
Shaharyar, A., Chaudhry, S., Jha, V., Bhadada, S. K., & Walia, R. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.02.008 · Cited by 1
Schillinger, M. O. (2014) · Endocrinology & Metabolic Syndrome · Cited by 1
Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction
Ćetković, A. (2008) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0808379c · Cited by 1
Viguera, S., & Jorge Carvajal, C. (2014) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262014000400015 · Cited by 1
Definition and Epidemiology of the Polycystic Ovary Syndrome
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_13 · Cited by 1
Self-citationInfertilidad e insulinorresistencia
Espinosa, E. S., & Esquivel, F. (2009) · Archivos de Investigación Materno Infantil · Cited by 1
Study of plasma adiponectin level in patients with metabolic syndrome
Ahmed, A., & Mohamed, N. (2015) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20151389 · Cited by 1
Vejražková, D. (2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.s12-001 · Cited by 1
Hyperinsulinemia in Polycystic Ovary Syndrome
Ammal, D. S. K. D. P. L. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i5.14 · Cited by 2
Nikpayam, O., & Sohrab, G. (2017) · Nutrition and Food Sciences Research · doi:10.29252/nfsr.4.4.2 · Cited by 1
Secondary Causes of Adipose Tissue Weight Gain
Hurley, D. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-95655-8_10 · Cited by 1
Obesity, Dysmetabolic and Proinflammatory Milieu of Polycystic Ovary Syndrome
Morong, J. J., & González, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_9 · Cited by 1
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Carreau, A., Battista, M., & Baillargeon, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_8 · Cited by 1
Wang, Y., Ma, R., Zou, Y., Wang, W., Zheng, Q., Feng, Y., Dong, H., Tan, Z., Zeng, X., Zhao, Y., et al. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2148649 · Cited by 1
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.13.019 · Cited by 1
Bertizlioğlu, M., Kebapçılar, A. G., Kebapçılar, L., Akyürek, F., Sert, Z. S., & Çelık, Ç. (2023) · Cureus · doi:10.7759/cureus.48875 · Cited by 1
Zaidieva, Y. Z., Balan, V. E., & Tsar’kova, A. V. (2023) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20232306125 · Cited by 2
Majeed, S., Moin, H., Shafi, R., Fatima, S., Zahra, T., & Zafar, S. (2024) · Women s Health · doi:10.1177/17455057241302559 · Cited by 1
Evaluation of insulin resistance in adolescent girl with menstrual irregularities
Kumari, S., Pankaj, S., Sinha, A., Prasad, D., & Kumar, R. (2015) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20151283 · Cited by 1
Metabolic Aspects of Polycystic Ovary Syndrome
Dhesi, A. S., & Morelli, S. S. (2015) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000471433.43201.11 · Cited by 1
Integrated Strategies for Enhancement of Fertility in PCOS
Coghlan, E., & Hart, R. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_21 · Cited by 1
Medical interventions to improve outcomes in infertile obese women planning for pregnancy
Talaulikar, V. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00016-4 · Cited by 1
Husseinand, M. R., Abdulwahid, H. H., Abo Almaali, H. M., & Ouda, M. H. (2021) · PLANT ARCHIVES · doi:10.51470/plantarchives.2021.v21.s1.004 · Cited by 1
Serum Podocalyxin Levels as High Risk Markers for CVDs of Complication of Diabetes
Al-fatlawiy, H. D. A., & Ali, H. A. (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i2.2900 · Cited by 1
Chandra, M., Vats, K., Garg, P., & Tibrewal, A. O. (2021) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20212548 · Cited by 1
IVF efficiency in different phenotypes of polycystic ovary syndrome
Nikolayenkov, I. P., Kazymova, O. E., Sudakov, D. S., & Dymarskaya, Y. R. (2021) · Journal of obstetrics and women s diseases · doi:10.17816/jowd61933 · Cited by 1
Villarroel, C., Henríquez, S., Kohen, P., & Devoto, L. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_7 · Cited by 1
Relación entre hipotiroidismo y síndrome de ovario poliquístico
López, J. A. G., Rivera-Contreras, O. E., & Sepúlveda-Agudelo, J. (2021) · Revista chilena de obstetricia y ginecología · doi:10.24875/rechog.m21000031 · Cited by 1
Síndrome de ovario poliquístico, el riesgo cardiovascular olvidado
Corredor-Rengifo, D., Pérez, T. B., Martinez, C. A. G., & Abreu-Lomba, A. (2023) · Interdisciplinary Journal of Epidemiology and Public Health · doi:10.18041/2665-427x/ijeph.1.10262
Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome
Escobar-Morreale, H. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_5 · Cited by 1
Guadix, B. R., Navarro, L. M., Rodríguez, M. Á. C., Jiménez, J. F., de la Cruz, R. L.-J. R., & López‐Criado, M. S. (2009) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(09)70341-3 · Cited by 1
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · Americanae (AECID Library) · Cited by 1
Metadata
- Authors
- DeUgarte, C. M., Bartolucci, A. A., & Azziz, R.
- Affiliations
- Cedars-Sinai Medical Center (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Azziz, Ricardo
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 83
- Issue
- 5
- Pages
- 1454-1460
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2117559317
- Cited by
- 589
- References
- 62
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 24 · 2023: 30 · 2022: 41 · 2021: 32 · 2020: 33 · 2019: 33 · 2018: 23 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 33 · 2013: 48 · 2012: 21
- FWCI
- 23.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, insulin resistance, HOMA-IR, beta-cell function, prevalence, obesity, sex hormones, insulin secretion
- MeSH terms
- Adult, Female, Homeostasis, Humans, Insulin Resistance, Middle Aged, Polycystic Ovary Syndrome, Prospective Studies, Prevalence, Chi-Square Distribution, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review